Annual report pursuant to Section 13 and 15(d)

SCHEDULE OF ANTIDILUTIVE SECURITIES EXCLUDED FROM COMPUTATION OF NET LOSS PER COMMON SHARE (Details)

v3.20.4
SCHEDULE OF ANTIDILUTIVE SECURITIES EXCLUDED FROM COMPUTATION OF NET LOSS PER COMMON SHARE (Details) - shares
12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Potential dilutive securities excluded from computation of dilutive weighted average shares outstanding 15,795,849 14,245,366
Warrant [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Potential dilutive securities excluded from computation of dilutive weighted average shares outstanding 1,506,206 1,000,000
Share-based Payment Arrangement, Option [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Potential dilutive securities excluded from computation of dilutive weighted average shares outstanding 14,289,643 13,245,366